Protagenic Therapeutics, Inc.\new Notes Payable, Current
Protagenic Therapeutics, Inc.\new (PTIX) had Notes Payable, Current of $3.16 million as of 2025-12-31, per its 10-Q filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-14
- 2025-12-31: Notes Payable, Current $3.16M.
- 2025-09-30: Notes Payable, Current $3.16M.
- 2025-06-30: Notes Payable, Current $3.16M.
- 2025-03-31: Notes Payable, Current $1.67M.
| Period end | Notes Payable, Current |
|---|---|
| 2025-12-31 | $3.16M 10-Q · filed 2026-03-09 |
| 2025-09-30 | $3.16M 10-Q · filed 2025-11-26 |
| 2025-06-30 | $3.16M 10-QT · filed 2025-09-10 |
| 2025-03-31 | $1.67M 10-K · filed 2026-08-14 |
| 2022-12-31 | $150.59K 10-K · filed 2023-03-31 |
| 2015-12-31 | $665.00K 10-Q · filed 2016-03-11 |
| 2015-09-30 | $565.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $0.00 10-Q · filed 2015-11-13 |
| 2015-03-31 | $415.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $415.00K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $265.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $0.00 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |